Plasmapp, Curexo agree on joint development of surgical robot solutions

South Korea's bioplasma technology firm Plasmapp said on Friday that it signed a memorandum of understanding with Curexo, a domestic medical robot manufacturer, to develop surgical robot solutions together.

Curexo will apply Plasmapp's ultra-fast low-temperature plasma sterilization solution to its medical robots to enhance the safety and efficiency of robotic surgery.

The two companies' major products have already been certified by regulators in some countries.

Plasmapp's plasma sterilizer obtained medical device licenses in Korea, Europe, Australia, Canada, Japan, Brazil, and the US while spiral surgery robots of Curexo were licensed in Korea, Europe, and the US.

A combination of Plasmapp's sterilization technology and Curexo's manufacturing strength will lead to the development of more competitive products with which they can more actively drive their global businesses.

"We have identified a market demand for safer and more efficient use of surgical robots. We will expand our applications to various surgical robots and continue global cooperation," said Lim Yoo-bong, CEO of Plasmapp.

Write to Ji-Hyun Lee at bluesky@hankyung.com